Allogeneic stem cell transplantation for children and Adolescents with CML: Conditioning regimen, donor selection, supportive care and diagnostic procedures.
Phase of Trial: Phase II/III
Latest Information Update: 24 Oct 2017
At a glance
- Drugs Fludarabine (Primary) ; Melphalan (Primary) ; Thiotepa (Primary) ; Antithymocyte globulin; Ciclosporin; Mycophenolate mofetil
- Indications Chronic myeloid leukaemia; Graft-versus-host disease
- Focus Therapeutic Use
- Acronyms CML-SCT-IBFM
- 18 Oct 2017 Planned End Date changed from 1 Jan 2022 to 1 Jan 2024.
- 18 Oct 2017 Planned primary completion date changed from 1 Jan 2017 to 1 Jan 2019.
- 07 Apr 2012 Additional trial location (Italy) identified as reported by European Clinical Trials Database